The spectrum of cutaneous lymphomas in Japan: A study of 62 cases based on the World Health Organization Classification

Journal of Cutaneous Pathology

Volumn 33, Issue 7, 2006, Pages 487-491

  Yasukawa, Kana ^a   Kato, Naoko ^a   Kodama, Kazuo ^a   Hamasaka, Asuka ^a   Hata, Hiroo ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; DERMATOLOGY; FEMALE; HUMAN; INCIDENCE; JAPAN; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYCOSIS FUNGOIDES; NATURAL KILLER CELL LYMPHOMA; SKIN DEFECT; SKIN LYMPHOMA; T CELL LEUKEMIA; T CELL LYMPHOMA; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; JAPAN; KILLER CELLS, NATURAL; LEUKEMIA, T-CELL; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; RETROSPECTIVE STUDIES; SEZARY SYNDROME; SKIN NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 33745899912     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00460.x     Document Type: Article

References (24)

1. Connors JM, Hsi ED, Foss FM. Lymphoma of the skin. Hematology (Am Soc Hematol Educ Program) 2002; 1: 263.
2. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354.3.
3. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization classification of tumors; pathology and genetics of tumors of hematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
4. Slater DN. The new World Health Organization classification of haematopoietic and lymphoid tumours: a dermatopathological perspective. Br J Dermatol 2002; 147: 633.
5. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous. Blood 2005; 105: 3768.
6. Sander CA, Flaig MJ, Jaffe ES. Cutaneous manifestations of lymphoma: a clinical guide based on the WHO classification. Clin Lymphoma 2001; 2: 86.
7. Lymphoma Study Group of Japanese Pathologists. The world health organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 2000; 50: 696.
8. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1998; 9: 717.
9. Kato N, Matsue K. Follicular lymphomatoid papulosis. Am J Dermatopathol 1997; 19: 189.
10. Kato N, Mizuno O, Ito K, Kimura K, Shibata M. Neutrophil-rich anaplastic large cell lymphoma presenting in the skin. Am J Dermatopathol 2003; 25: 142.
11. Kato N, Yasukawa K, Onozuka T, Kikuta H. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement. J Am Acad Dermatol 1999; 40: 850.
12. Kato N, Sugawara H, Aoyagi S, Mayuzumi M. Lymphoma-type adult T-cell leukaemia-lymphoma with a bulky cutaneous tumour showing multiple human T-lymphotropic virus-1 DNA integration. Br J Dermatol 2001; 144: 1244.
13. + hematodermic/hematolymphoid malignancy. J Am Acad Dermatol 2001; 44: 231.
14. Nagasawa T, Miwa H, Nakatsuka S, Itami S, Yoshikawa K, Aozasa K. Characteristics of cutaneous lymphomas in Osaka, Japan (1988) based on the European Organization for Research and Treatment of Cancer classification. Am J Dermatopathol 2000; 22: 510.
15. Lee MW, Korean Dermatopathology Research Group. Characteristics of cutaneous lymphomas in Korea. Clin Exp Dermatol 2003; 28: 639.
16. Fink-Puches R, Zenahlik P, Back B, Smolle J, Kerl H, Cerroni L. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 2002; 99: 800.
17. Geelen FA, Vermeer MH, Meijer CJ, et al. Bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related. J Clin Oncol 1998; 16: 2080.
18. Grange F, Petrella T, Beylot-Barry M, et al. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. Blood 2004; 103: 3662.
19. Cerroni L, Zochling N, Putz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457.
20. Suefuji H, Ohshima K, Hayabuchi N, Nakamura K, Kikuchi M. HTLV-1 carriers with B-cell lymphoma of localized stage head and neck: prognosis, clinical and immunopathological features. Br J Haematol 2003; 123: 606.
21. Shibata K, Shimamoto Y, Nakano S, Miyahara M, Nakano H, Yamaguchi M. Mantle cell lymphoma with the features of mucosa-associated lymphoid tissue (MALT) lymphoma in an HTLV-I-seropositive patient. Ann Hematol 1995; 70: 47.
22. Tobinai K, Ohtsu T, Hayashi M, et al. Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma. Leuk Res 1991; 15: 837.
23. Murphy GF, Schwarting R. Cutaneous lymphomas and leukemias. In: Elder DE, ed. Lever's histopathology of the skin. Philadelphia: Lippincott Williams & Wilkins, 2004; 927.
24. Ishiji T, Takagi Y, Niimura M. Cutaneous lymphomas in Tokyo: analysis of 62 cases in a dermatology clinic. Int J Dermatol 2001; 40: 37.